Fundraising Fox
Laxmi Therapeutic Devices
Goleta, US · Delaware corporation
Find your way into Laxmi Therapeutic Devices
Sign up to see every warm intro you have to Laxmi Therapeutic Devices
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Laxmi Therapeutic Devices team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Laxmi Therapeutic Devices develops wearable diabetes management technology to improve patient health outcomes and time in range.
Founders & leadership
PR
Peter RuleChief Executive Officer
GS
Greg SnelsonExecutive
SP
Sumita PennathurNamed on SEC filing
JG
John GerngrossSecretary
Board
MB
Matthew BergerBoard director
JL
John LivingstonBoard director
BV
Bill Van AntwerpBoard director
RS
Rachael SchererBoard director
Reported raises · per SEC filings
Form D private placements$60.4M disclosed across 10 rounds · 2016–2026
▶$2.1MraisedJul 2026 · 5 investors · OtherRule 506(b)
▶$2.1MraisedJul 2026 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Peter RuleExecutive Officer, Director
- Greg SnelsonExecutive Officer
- Sumita PennathurDirector
- John LivingstonDirector
- Matthew BergerDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedFeb 2025 · 5 investors · OtherRule 506(b)
▶$15MraisedFeb 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John GerngrossExecutive Officer, Director
- Peter RuleExecutive Officer, Director
- Sumita PennathurDirector
- Matthew BergerDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2023 · 4 investors · OtherRule 506(b)
▶$5MraisedNov 2023 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew BergerDirector
- Sumita PennathurExecutive Officer, Director
- John GerngrossDirector
- Greg SnelsonExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedJul 2022 · 6 investors · OtherRule 506(b)
▶$9MraisedJul 2022 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John GerngrossDirector
- Bill Van AntwerpDirector
- Greg SnelsonExecutive Officer
- Matthew BergerDirector
- Sumita PennathurExecutive Officer, Director
- Rachael SchererDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.2MraisedApr 2021 · 4 investors · OtherRule 506(b)
▶$13.2MraisedApr 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew BergerDirector
- Sumita PennathurExecutive Officer, Director
- John GerngrossDirector
- Bill Van AntwerpDirector
- Rachael SchererDirector
- Offering amount
- $13.2M
- Amount sold
- $13.2M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedOct 2020 · 2 investors · OtherRule 506(b)
▶$6MraisedOct 2020 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sumita PennathurExecutive Officer, Director
- Bill Van AntwerpDirector
- Radhika KrishnanDirector
- John GerngrossDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$6MraisedDec 2019 · 3 investors · OtherRule 506(b)
▶$6MraisedDec 2019 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Radhika KrishmanDirector
- Bill Van AntweryDirector
- John GerngrossDirector
- Sumita PennathurExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$2.5MraisedDec 2017 · 2 investors · Other TechnologyRule 506(b)
▶$2.5MraisedDec 2017 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John GerngrossDirector
- Sumita PennathurExecutive Officer, Director
- Richard LowDirector
- Bill Van AntwerpDirector
- Luke TheogarajanExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
DiabetesA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Companies working in the same space as Laxmi Therapeutic Devices.
Frequently asked questions
- What does Laxmi Therapeutic Devices do?
- Laxmi Therapeutic Devices develops wearable diabetes management technology to improve patient health outcomes and time in range.
- How much funding has Laxmi Therapeutic Devices raised?
- Laxmi Therapeutic Devices has disclosed $60.4M raised across 10 rounds.
- Where is Laxmi Therapeutic Devices headquartered?
- Laxmi Therapeutic Devices is headquartered in Goleta, US.